Search Results

There are 16079 results for: content related to: Novel approaches in the treatment of systemic mastocytosis

  1. You have full text access to this Open Access content
    Activity of triptolide against human mast cells harboring the kinase domain mutant KIT

    Cancer Science

    Volume 100, Issue 7, July 2009, Pages: 1335–1343, Yanli Jin, Qi Chen, Xianping Shi, Zhongzheng Lu, Chao Cheng, Yingrong Lai, Qin Zheng and Jingxuan Pan

    Version of Record online : 12 MAR 2009, DOI: 10.1111/j.1349-7006.2009.01159.x

  2. You have free access to this content
    Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis

    Cancer

    Volume 117, Issue 24, 15 December 2011, Pages: 5439–5449, Alfonso Quintás-Cardama, Nitin Jain and Srdan Verstovsek

    Version of Record online : 20 JUN 2011, DOI: 10.1002/cncr.26256

  3. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Version of Record online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  4. You have free access to this content
    Current treatment options in patients with mastocytosis: status in 2015 and future perspectives

    European Journal of Haematology

    Volume 94, Issue 6, June 2015, Pages: 474–490, Michel Arock, Cem Akin, Olivier Hermine and Peter Valent

    Version of Record online : 26 MAR 2015, DOI: 10.1111/ejh.12544

  5. You have free access to this content
    Recent advances in the understanding of mastocytosis: the role of KIT mutations

    British Journal of Haematology

    Volume 138, Issue 1, July 2007, Pages: 12–30, Alberto Orfao, Andrés C. Garcia-Montero, Laura Sanchez and Luis Escribano

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-2141.2007.06619.x

  6. You have free access to this content
    Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders

    British Journal of Pharmacology

    Volume 154, Issue 8, August 2008, Pages: 1572–1582, B M Jensen, C Akin and A M Gilfillan

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.204

  7. C-kit mutations and PKC crosstalks: PKC translocates to nucleous only in cells HMC560,816

    Journal of Cellular Biochemistry

    Volume 112, Issue 9, September 2011, Pages: 2637–2651, Araceli Tobío, Amparo Alfonso and Luis M. Botana

    Version of Record online : 18 AUG 2011, DOI: 10.1002/jcb.23191

  8. Targeted ultradeep next-generation sequencing as a method for KITD816V mutation analysis in mastocytosis

    European Journal of Haematology

    Volume 96, Issue 4, April 2016, Pages: 381–388, Thomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Michael Boe Møller and on behalf of the Mastocytosis Centre Odense University Hospital (MastOUH)

    Version of Record online : 26 JUN 2015, DOI: 10.1111/ejh.12601

  9. You have free access to this content
    The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes

    British Journal of Pharmacology

    Volume 158, Issue 3, October 2009, Pages: 907–919, K Nagai, Y Takahashi, I Mikami, T Fukusima, H Oike and M Kobori

    Version of Record online : 20 AUG 2009, DOI: 10.1111/j.1476-5381.2009.00365.x

  10. You have full text access to this OnlineOpen article
    NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation

    Allergy

    Volume 67, Issue 7, July 2012, Pages: 858–868, E. Hadzijusufovic, B. Peter, H. Herrmann, T. Rülicke, S. Cerny-Reiterer, K. Schuch, L. Kenner, T. Thaiwong, V. Yuzbasiyan-Gurkan, W. F. Pickl, M. Willmann and P. Valent

    Version of Record online : 15 MAY 2012, DOI: 10.1111/j.1398-9995.2012.02833.x

  11. You have full text access to this OnlineOpen article
    Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

    European Journal of Haematology

    Volume 90, Issue 2, February 2013, Pages: 89–98, Srdan Verstovsek

    Version of Record online : 22 JAN 2013, DOI: 10.1111/ejh.12043

  12. You have free access to this content
    Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management

    American Journal of Hematology

    Volume 91, Issue 11, November 2016, Pages: 1146–1159, Animesh Pardanani

    Version of Record online : 20 OCT 2016, DOI: 10.1002/ajh.24553

  13. You have free access to this content
    Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene

    Immunology

    Volume 108, Issue 1, January 2003, Pages: 89–97, Magnus Sundström, Harissios Vliagoftis, Peter Karlberg, Joseph H. Butterfield, Kenneth Nilsson, Dean D. Metcalfe and Gunnar Nilsson

    Version of Record online : 10 JAN 2003, DOI: 10.1046/j.1365-2567.2003.01559.x

  14. You have free access to this content
    Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management

    American Journal of Hematology

    Volume 88, Issue 7, July 2013, Pages: 612–624, Animesh Pardanani

    Version of Record online : 30 MAY 2013, DOI: 10.1002/ajh.23459

  15. Different Role of cAMP Pathway on the Human Mast Cells HMC-1560 and HMC-1560,816 Activation

    Journal of Cellular Biochemistry

    Volume 115, Issue 5, May 2014, Pages: 896–909, Olalla Barreiro-Costa, Araceli Tobío, Amparo Alfonso and Luis M. Botana

    Version of Record online : 4 MAR 2014, DOI: 10.1002/jcb.24732

  16. You have free access to this content
    Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 250–262, Animesh Pardanani

    Version of Record online : 17 FEB 2015, DOI: 10.1002/ajh.23931

  17. You have free access to this content
    Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium

    American Journal of Hematology

    Volume 87, Issue 5, May 2012, Pages: 562–568, Omar Abdel-Wahab, Animesh Pardanani, Olivier A. Bernard, Guido Finazzi, John D. Crispino, Heinz Gisslinger, Robert Kralovics, Olatoyosi Odenike, Kapil Bhalla, Vikas Gupta, Giovanni Barosi, Jason Gotlib, Paola Guglielmelli, Jean-Jacques Kiladjian, Pierre Noel, Mario Cazzola, Alessandro M. Vannucchi, Ronald Hoffman, Tiziano Barbui, Juergen Thiele, Richard A. Van Etten, Tariq Mughal and Ayalew Tefferi

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ajh.23169

  18. Lung epithelial H292 cells induce differentiation of immature human HMC-1 mast cells by interleukin-6 and stem cell factor

    Clinical & Experimental Allergy

    Volume 30, Issue 8, August 2000, Pages: 1104–1112, Pompen, * Smids, * Dingemans, Jansen, * Out and Lutter *

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.2000.00881.x

  19. Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis

    Clinical and Experimental Dermatology

    Volume 38, Issue 5, July 2013, Pages: 538–544, I. J. Chan, S. Kasprowicz and M. D. Tharp

    Version of Record online : 18 JUN 2013, DOI: 10.1111/ced.12000

  20. You have free access to this content
    Advances in Understanding and Management of Myeloproliferative Neoplasms

    CA: A Cancer Journal for Clinicians

    Volume 59, Issue 3, May/June 2009, Pages: 171–191, Alessandro M. Vannucchi, Paola Guglielmelli and Ayalew Tefferi

    Version of Record online : 16 APR 2009, DOI: 10.3322/caac.20009